CATHY LUCAS: Open Payments
NPI 1124695606 · OTTAWA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,236 in 128 payments from 18 companies in 2025. Trend: 2023 $1,286 · 2024 $2,895 · 2025 $2,236
Food & beverage: $2,236
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $451 |
| Lucid Diagnostics Inc. | 23 | $353 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $313 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $292 |
| Janssen Biotech, Inc. | 7 | $225 |
| Ardelyx, Inc. | 5 | $109 |
| Ferring Pharmaceuticals Inc. | 2 | $70 |
| PFIZER INC. | 3 | $70 |
| Madrigal Pharmaceuticals | 4 | $61 |
| QOL Medical, LLC | 3 | $51 |
Products named: XIFAXAN, TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, EOHILIA, IBSRELA, REBYOTA.
Industry payments across OH — which companies pay providers there.
